NPPA issued a notification regarding the fixation of the retail price of Rosuvastatin Calcium IP eq. to Rosuvastatin 10 mg + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg for M/s Sun Pharma Laboratories Ltd. (Manufacturer & Marketer)

Jan 22, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on January 21, 2026, issued a notification regarding the fixation of the retail price of Rosuvastatin Calcium IP eq. to Rosuvastatin 10 mg + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg for M/s Sun Pharma Laboratories Ltd. (Manufacturer & Marketer).

The following has been stated: -

•Each film-coated tablet contains: Rosuvastatin Calcium IP eq. to Rosuvastatin 10 mg + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg for M/s Sun Pharma Laboratories Ltd. (Manufacturer & Marketer) and the retail price is 16.32 Rs.

[Notification No.: 19 (4990)/2026/DP/NPPA/Div.III/12967/2026]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT